Vera Therapeutics VERA Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by Vera Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.
The official record: Vera Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vera Therapeutics's interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vera Therapeutics's interest income?
- Vera Therapeutics (VERA) reported interest income of $6.36M in Q1 2026.
- How has Vera Therapeutics's interest income changed year-over-year?
- Vera Therapeutics's interest income decreased by 8.0% year-over-year, from $6.91M to $6.36M.
- What is the long-term trend for Vera Therapeutics's interest income?
- Over 4 years (2021 to 2025), Vera Therapeutics's interest income has grown at a 535.6% compound annual growth rate (CAGR), from $15K to $24.48M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.